Nothing compares to bringing together startups, investors and ultimate acquirers/customers in a specific market. The SCOPE Investor track delivered this in spades for the clinical trial market.

Founder & Managing Partner, SPRIG Equity

It was truly a pleasure participating in this excellent SCOPE Investor and Innovation Conference. It was my first SCOPE experience and I will be back!

Global Head, Healthcare + Life Sciences, Amazon Web Services LLC

The SCOPE 2023 conference marked an exciting inflection point for the clinical trial industry as the future of clinical trials is unfolding. With the caliber of tracks, sessions, speakers, panels resulting in timely and provocative topics, SCOPE has become an important meeting that can't be missed. I left the conference thinking about how much we as an industry have evolved, how much more there is to do and how SCOPE is a great meeting place for advancing the industry.

Founder, Hawthorne Effect, Inc.

Software innovation in the clinical domain, and pharma more broadly, is one of our top priorities – SCOPE is a fantastic venue to get together with thought leaders, innovators, and of course our portfolio companies sharing our passion for the space.

Vice President, Insight Partners